Salomon Manier | Videos & Research | VJHemOnc
Primary refractory young myeloma: a difficult clinical situation - YouTube
IACH on X: "Join us TODAY at 2pm Eastern Time (Atlanta), 8pm CET (Paris) for live news from #ASH21 with Dr. Salomon Manier and @Mohty_EBMT Register Free here: https://t.co/bdQmP2b0TS https://t.co/oYQD70BBZf" / X
Pr Salomon MANIER - Auteur | Edimark
JNM2022 les traitements de la rechute - YouTube
Première mondiale au CHU de Lille dans le traitement du cancer de la moelle osseuse - CHU Lille
Pr Salomon MANIER - Auteur | Edimark
ASH 2022: Multiple Myeloma Highlights - The ASCO Post
Pr Salomon MANIER - Auteur | Edimark
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation
Taper sur TOPORS rendrait l'AZA plus FORT… à l'aTAK ! ASH 2022 - E-journal | Edimark.fr
L'ARC soutient les recherches menées à l'IRCL - IRCL
Team : Factors of persistence of leukemic cells - Canther
CHU de Lille: avancée majeure espérée dans le traitement du cancer de la moelle osseuse - La Voix du Nord
ide-cel and neurotoxicity | Int'l Myeloma Foundation
Multiple Myeloma Hub on X: "#EHA2023 | Salomon Manier @CHU_Lille shares efficacy and safety data on BCMA targeted drugs: CAR T, bispecifics and antibody-drug conjugates. Future directions of CAR T cells include
Première mondiale au CHU de Lille dans le traitement du cancer de la moelle osseuse - CHU Lille
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
IACH Journal Club – International Academy for Clinical Hematology (IACH)
Therapy of relapsed-refractory multiple myeloma - Springer Healthcare IME
